Japan’s largest drugmaker Takeda (announced new Phase III data for zasocitinib, its investigational, next-generation, highly ...

UK biotech company Mission Therapeutics has agreed to hand its acute kidney injury candidate MTX652 to Australian renal ...

Latin American countries need to treat health spending as an investment rather than a cost if they are to expand coverage, ...

US lawmakers have introduced bipartisan legislation that would reduce routine reliance on comparative clinical efficacy studies in biosimilar approvals, a move welcomed by the Association for ...

US healthcare major Johnson & Johnson (NYSE: JNJ) reported second-quarter 2026 sales of $25.31 billion, up 6.6% on the year, ...

Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...

Swiss generics and biosimilars company Sandoz (SIX: SDZ) has announced a set of senior leadership changes designed to sharpen its operations and dealmaking ahead of what it calls a "golden decade" of ...

India's Zydus Lifesciences has entered into a strategic deal to acquire select assets of Sterling Biotech, strengthening its ...

New Jersey, USA-based Adneuris Therapeutics, a subsidiary of Tris Pharma advancing a new kind of pain medicine, today ...

US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based ...

Cambridge, USA-based biotech Spero Therapeutics on Tuesday announced a $105 million non-recourse, non-dilutive royalty ...

Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...